Oncosem applies for 1200% bonus capital increase

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A. Ş. (ONCSM) has officially applied to the Capital Markets Board (SPK) for a 1200% bonus capital increase. The application was submitted on August 8, 2026, following a board decision made on July 16, 2026.

The company intends to increase its current paid-in capital from 23,850,000 TL to 310,050,000 TL. This 286,200,000 TL increase will be funded entirely through internal resources, including 115,990,367.05 TL from emission premiums, 96,621,278.24 TL from equity inflation adjustment differences, and 73,588,354.71 TL from other profit reserves.

To facilitate this, the company will exceed its current registered capital ceiling of 99,000,000 TL for this one-time transaction. New shares will be distributed to shareholders according to their existing proportions, maintaining the distinction between Group A privileged shares and Group B bearer shares. The distribution date will be announced following approval from the SPK.